Feb 28 |
Q4 2023 Supernus Pharmaceuticals Inc Earnings Call
|
Feb 28 |
Supernus Pharmaceuticals, Inc. (SUPN) Q4 2023 Earnings Call Transcript
|
Feb 28 |
Supernus (SUPN) Reports Q4 Earnings: What Key Metrics Have to Say
|
Feb 27 |
Supernus Pharmaceuticals (SUPN) Lags Q4 Earnings Estimates
|
Feb 27 |
Supernus Pharmaceuticals Inc (SUPN) Reports Robust Growth in Key Products for Full Year 2023
|
Feb 27 |
Supernus Pharmaceuticals GAAP EPS of $0.02 beats by $0.04, revenue of $164.3M beats by $9.27M
|
Feb 27 |
Supernus Announces Fourth Quarter and Full Year 2023 Financial Results
|
Feb 26 |
Supernus Pharmaceuticals Q4 2023 Earnings Preview
|
Feb 26 |
Ahead of Supernus (SUPN) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
|
Feb 20 |
Analysts Estimate Supernus Pharmaceuticals (SUPN) to Report a Decline in Earnings: What to Look Out for
|